23-Valent Pneumococcal Polysaccharide Vaccine Market Report

Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 29, 2022
  • PAGES：212
  • REPORT CODE：GMM1505453
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the 23-Valent Pneumococcal Polysaccharide Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • MSD

    • Sanofipasteur

    • CDIBP

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Single Dose Vial

    • Pre-filled Syringe

    Application:

    • For Children (2-10)

    • For Person (10-64)

    • For The old (Above 65)

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Overview

      • 1.1.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Scope and Market Segments

      • 1.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Industry Characteristics

      • 1.1.3 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Single Dose Vial

      • 1.2.2 Pre-filled Syringe

    • 1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 For Children (2-10)

      • 1.3.2 For Person (10-64)

      • 1.3.3 For The old (Above 65)

    • 1.4 Market Analysis by Region

      • 1.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Industry PEST Analysis

    • 2.3 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on 23-Valent Pneumococcal Polysaccharide Vaccine Industry

    Chapter 3 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Manufacturer

    • 3.1 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market Top 3 Players

    Chapter 4 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Type (2017-2028)

    • 4.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Trend, by Type

    • 4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis

    • 7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Type

    • 7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Application

    • 7.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis

    • 8.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Type

    • 8.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Application

    • 8.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis

    • 9.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Type

    • 9.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Application

    • 9.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Company Profiles

      • 11.1 MSD

        • 11.1.1 MSD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Profiles, Application and Specification

        • 11.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sanofipasteur

        • 11.2.1 Sanofipasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Profiles, Application and Specification

        • 11.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 CDIBP

        • 11.3.1 CDIBP Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Profiles, Application and Specification

        • 11.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 23-Valent Pneumococcal Polysaccharide Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 23-Valent Pneumococcal Polysaccharide Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate of Single Dose Vial (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate of Pre-filled Syringe (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate of For Children (2-10) (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate of For Person (10-64) (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and Growth Rate of For The old (Above 65) (2017-2028)

    • Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China 23-Valent Pneumococcal Polysaccharide Vaccine Market Share, by Manufacturer in 2022

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Type (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value, by Type (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Trend, by Type (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Type (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value, by Type (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Price Trend, by Type (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Application (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value, by Application (2017-2028)

    • Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Share, by Application (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Application (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value, by Application (2017-2028)

    • Table China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Type (2017-2028)

    • Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Application (2017-2028)

    • Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales Value and Growth Rate (2017-2028)

    • Table MSD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MSD Product Profiles, Application and Specification

    • Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofipasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofipasteur Product Profiles, Application and Specification

    • Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CDIBP Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CDIBP Product Profiles, Application and Specification

    • Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US